Crescent Biopharma Inc (Pre-Reincorporation)
NASDAQ:CBIO

Watchlist Manager

Crescent Biopharma Inc (Pre-Reincorporation)

NASDAQ:CBIO

Watchlist

Dividends

Price: 13.8 USD 1.47% Market Closed

Market Cap: 191.7m USD

Have any thoughts about
Crescent Biopharma Inc (Pre-Reincorporation)?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 13.8 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

CBIO Alert

Crescent Biopharma Inc (Pre-Reincorporation)

13.8

+0.2 (+1.47%)

52 Week Range	11 49
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Crescent Biopharma Inc (Pre-Reincorporation)

What unique competitive advantages
does Crescent Biopharma Inc (Pre-Reincorporation) hold over its rivals?

What risks and challenges
does Crescent Biopharma Inc (Pre-Reincorporation) face in the near future?

Provide an overview of the primary business activities
of Crescent Biopharma Inc (Pre-Reincorporation).

Show me price targets
for Crescent Biopharma Inc (Pre-Reincorporation) made by professional analysts.

Provide an overview of the primary business activities
of Crescent Biopharma Inc (Pre-Reincorporation).

What unique competitive advantages
does Crescent Biopharma Inc (Pre-Reincorporation) hold over its rivals?

What risks and challenges
does Crescent Biopharma Inc (Pre-Reincorporation) face in the near future?

Has there been any significant insider trading activity
in Crescent Biopharma Inc (Pre-Reincorporation) recently?

Summarize the latest earnings call
of Crescent Biopharma Inc (Pre-Reincorporation).

Show all valuation multiples
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide P/S
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide P/E
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide P/OCF
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide P/FCFE
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide P/B
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide EV/S
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide EV/GP
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide EV/EBITDA
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide EV/EBIT
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide EV/OCF
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide EV/FCFF
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide EV/IC
for Crescent Biopharma Inc (Pre-Reincorporation).

Show me price targets
for Crescent Biopharma Inc (Pre-Reincorporation) made by professional analysts.

What are the Revenue projections
for Crescent Biopharma Inc (Pre-Reincorporation)?

How accurate were the past Revenue estimates
for Crescent Biopharma Inc (Pre-Reincorporation)?

What are the Net Income projections
for Crescent Biopharma Inc (Pre-Reincorporation)?

How accurate were the past Net Income estimates
for Crescent Biopharma Inc (Pre-Reincorporation)?

What are the EPS projections
for Crescent Biopharma Inc (Pre-Reincorporation)?

How accurate were the past EPS estimates
for Crescent Biopharma Inc (Pre-Reincorporation)?

What are the EBIT projections
for Crescent Biopharma Inc (Pre-Reincorporation)?

How accurate were the past EBIT estimates
for Crescent Biopharma Inc (Pre-Reincorporation)?

Compare the revenue forecasts
for Crescent Biopharma Inc (Pre-Reincorporation) with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Crescent Biopharma Inc (Pre-Reincorporation) and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Crescent Biopharma Inc (Pre-Reincorporation) against its competitors.

Analyze the profit margins
(gross, operating, and net) of Crescent Biopharma Inc (Pre-Reincorporation) compared to its peers.

Compare the P/E ratios
of Crescent Biopharma Inc (Pre-Reincorporation) against its peers.

Discuss the investment returns and shareholder value creation
comparing Crescent Biopharma Inc (Pre-Reincorporation) with its peers.

Analyze the financial leverage
of Crescent Biopharma Inc (Pre-Reincorporation) compared to its main competitors.

Show all profitability ratios
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide ROE
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide ROA
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide ROIC
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide ROCE
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide Gross Margin
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide Operating Margin
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide Net Margin
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide FCF Margin
for Crescent Biopharma Inc (Pre-Reincorporation).

Show all solvency ratios
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide D/E Ratio
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide D/A Ratio
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide Interest Coverage Ratio
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide Altman Z-Score Ratio
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide Quick Ratio
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide Current Ratio
for Crescent Biopharma Inc (Pre-Reincorporation).

Provide Cash Ratio
for Crescent Biopharma Inc (Pre-Reincorporation).

What is the historical Revenue growth
over the last 5 years for Crescent Biopharma Inc (Pre-Reincorporation)?

What is the historical Net Income growth
over the last 5 years for Crescent Biopharma Inc (Pre-Reincorporation)?

What is the current Free Cash Flow
of Crescent Biopharma Inc (Pre-Reincorporation)?

Discuss the annual earnings per share (EPS)
trend over the past five years for Crescent Biopharma Inc (Pre-Reincorporation).

Wall Street Price Targets Revenue Forecast Operating Income Forecast Net Income Forecast See Also

Section:

Wall Street Price Targets

Revenue Forecast

Operating Income Forecast

Net Income Forecast

Wall Street
Price Targets

CBIO Price Targets Summary
Crescent Biopharma Inc (Pre-Reincorporation)

Wall Street analysts forecast CBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CBIO is 26.18 USD with a low forecast of 22.22 USD and a high forecast of 29.4 USD.

CBIO Average Forecast

Wall Street Target

26.18 USD

90% Upside

CBIO Highest Forecast

Wall Street Target

29.4 USD

113% Upside

Lowest

Price Target

22.22 USD

61% Upside

Average

Price Target

26.18 USD

90% Upside

Highest

Price Target

29.4 USD

113% Upside

Crescent Biopharma Inc (Pre-Reincorporation) Competitors:
Price Targets

000403

Pacific Shuanglin Bio pharmacy Co Ltd

20% Upside

CRSP

CRISPR Therapeutics AG

53% Upside

PRAX

Praxis Precision Medicines Inc

131% Upside

ARQT

Arcutis Biotherapeutics Inc

37% Upside

000403

Pacific Shuanglin Bio pharmacy Co Ltd

20% Upside

CRSP

CRISPR Therapeutics AG

53% Upside

PRAX

Praxis Precision Medicines Inc

131% Upside

ARQT

Arcutis Biotherapeutics Inc

37% Upside

145020

Hugel Inc

48% Upside

ENTA

Enanta Pharmaceuticals Inc

102% Upside

VNDA

Vanda Pharmaceuticals Inc

181% Upside

DVYSR

Devyser Diagnostics AB

22% Upside

Revenue
Forecast

Revenue Estimate
Crescent Biopharma Inc (Pre-Reincorporation)

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-5%

Average Miss

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Crescent Biopharma Inc (Pre-Reincorporation)

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-2%

Average Miss

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Crescent Biopharma Inc (Pre-Reincorporation)

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-97%

Average Miss

What are analyst estimates?

What is CBIO's stock price target?

Price Target
26.18 USD

According to Wall Street analysts, the average 1-year price target for CBIO is 26.18 USD with a low forecast of 22.22 USD and a high forecast of 29.4 USD.

	Crescent Biopharma Inc (Pre-Reincorporation) NASDAQ:CBIO	13.8 USD 1.47%
	Flugger group A/S CSE:FLUG B	356 DKK 0.56%
	WISR Ltd ASX:WZR	0.031 AUD -3.13%

	Franklin Covey Co NYSE:FC	18.91 USD -3.62%
	Mohawk Industries Inc NYSE:MHK	124.05 USD -2.93%
	Ardmore Shipping Corp NYSE:ASC	10.98 USD 2.52%
	ASGN Inc NYSE:ASGN	51.57 USD -2.01%
	Skyworks Solutions Inc NASDAQ:SWKS	75.12 USD 0.25%
	Weatherford International PLC NASDAQ:WFRD	56.36 USD 0.07%

	Johnson & Johnson NYSE:JNJ	178.84 USD 0.58%
	Bank of America Corp NYSE:BAC	48.35 USD 0.56%
	Mastercard Inc NYSE:MA	592.68 USD 1.22%
	Salesforce Inc NYSE:CRM	246.45 USD 0.18%
	Abbvie Inc NYSE:ABBV	209.15 USD 1.44%
	Home Depot Inc NYSE:HD	401.74 USD -1.34%

	Monolithic Power Systems Inc NASDAQ:MPWR	826.27 USD -2.19%
	Applovin Corp NASDAQ:APP	412.38 USD -0.05%
	NVIDIA Corp NASDAQ:NVDA	175.4 USD -0.14%
	Cal-Maine Foods Inc NASDAQ:CALM	114.2 USD 3.76%
	Pro Medicus Ltd ASX:PME	303.8 AUD -1.23%
	Thor Explorations Ltd XTSX:THX	0.92 CAD 4.55%

	Salesforce Inc NYSE:CRM	246.45 USD 0.18%
	Accenture PLC NYSE:ACN	255.05 USD -0.32%
	ServiceNow Inc NYSE:NOW	890.25 USD 0.39%
	Spotify Technology SA NYSE:SPOT	703.79 USD -2.16%
	Applied Materials Inc NASDAQ:AMAT	160.96 USD -0.78%
	Synopsys Inc NASDAQ:SNPS	601.13 USD -1.9%

Crescent Biopharma Inc (Pre-Reincorporation)
NASDAQ:CBIO

Wall Street
Price Targets

CBIO Price Targets Summary
Crescent Biopharma Inc (Pre-Reincorporation)

Revenue
Forecast

Revenue Estimate
Crescent Biopharma Inc (Pre-Reincorporation)

Operating Income
Forecast

Operating Income Estimate
Crescent Biopharma Inc (Pre-Reincorporation)

Net Income
Forecast

Net Income Estimate
Crescent Biopharma Inc (Pre-Reincorporation)

See Also

What is CBIO's stock price target?

Price Target
26.18 USD

Company

Help

Tools

Stocks

Crescent Biopharma Inc (Pre-Reincorporation) NASDAQ:CBIO

Wall Street Price Targets

CBIO Price Targets Summary Crescent Biopharma Inc (Pre-Reincorporation)

Revenue Forecast

Revenue Estimate Crescent Biopharma Inc (Pre-Reincorporation)

Operating Income Forecast

Operating Income Estimate Crescent Biopharma Inc (Pre-Reincorporation)

Net Income Forecast

Net Income Estimate Crescent Biopharma Inc (Pre-Reincorporation)

See Also

What is CBIO's stock price target? Price Target 26.18 USD

Company

Help

Tools

Stocks

Crescent Biopharma Inc (Pre-Reincorporation)
NASDAQ:CBIO

Wall Street
Price Targets

CBIO Price Targets Summary
Crescent Biopharma Inc (Pre-Reincorporation)

Revenue
Forecast

Revenue Estimate
Crescent Biopharma Inc (Pre-Reincorporation)

Operating Income
Forecast

Operating Income Estimate
Crescent Biopharma Inc (Pre-Reincorporation)

Net Income
Forecast

Net Income Estimate
Crescent Biopharma Inc (Pre-Reincorporation)

What is CBIO's stock price target?

Price Target
26.18 USD